ACXP | NASDAQ

Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. (ACXP) | runway 29.2 months | financing risk elevated | market cap $5.9M. Daily snapshot of financials, capital pressure, and rec...

Company websiteLast updated Apr 29, 2026

Share price

$1.97

As of Apr 29, 2026

Market cap

$5.9M

Snapshot valuation

30D volume

540,907 shares

Rolling average daily volume

Runway

29.2 months

Estimated from precomputed burn and cash

Financing risk

N/A

Current liquidity and financing setup suggest the company may need fresh capital in the near term.

Snapshot summary

Runway: 29.2 months based on estimated burn.

Recent financing detected on Apr 15, 2026.

Financing signal: Current liquidity and financing setup suggest the company may need fresh capital in the near term.

Recent developments

Acurx Pharmaceuticals, Inc. 8-K 2026-04-16

8-K filed on 2026-04-16.

Apr 15, 2026, 8:00 PM

Acurx Pharmaceuticals, Inc. 424B5 2026-04-16

424B5 filing submitted on 2026-04-16.

Apr 15, 2026, 8:00 PM

Acurx Pharmaceuticals, Inc. 10-K 2026-03-12

10-K filed on 2026-03-12.

Mar 11, 2026, 8:00 PM

Acurx Pharmaceuticals, Inc. 8-K 2026-03-09

8-K filed on 2026-03-09.

Mar 8, 2026, 8:00 PM

Acurx Pharmaceuticals, Inc. 424B3 2026-02-11

424B3 filing submitted on 2026-02-11.

Feb 10, 2026, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures